Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Fortrea Holdings Inc. (FTRE)

5.66
+0.34
+(6.39%)
As of 1:34:27 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,696,400
2,696,400
2,842,500
2,837,000
3,057,500
Cost of Revenue
2,162,200
2,162,200
2,251,900
2,112,600
2,453,100
Gross Profit
534,200
534,200
590,600
724,400
604,400
Operating Expense
646,000
646,000
537,400
501,600
469,400
Operating Income
-111,800
-111,800
53,200
222,800
135,000
Net Non Operating Interest Income Expense
-123,800
-123,800
-69,700
-200
-200
Other Income Expense
-39,400
-39,400
-14,000
-35,600
1,600
Pretax Income
-275,000
-275,000
-30,500
187,000
136,400
Tax Provision
-3,500
-3,500
1,200
41,100
38,400
Net Income Common Stockholders
-328,500
-328,500
-25,200
186,200
98,000
Diluted NI Available to Com Stockholders
-328,500
-328,500
-25,200
186,200
98,000
Basic EPS
-3.36
-3.67
-0.29
2.11
1.11
Diluted EPS
-3.36
-3.67
-0.29
2.11
1.11
Basic Average Shares
89,250
89,509.54
88,800
88,400
88,400
Diluted Average Shares
89,250
89,509.54
88,800
88,400
88,400
Total Operating Income as Reported
-161,900
-161,900
32,000
187,100
114,300
Total Expenses
2,808,200
2,808,200
2,789,300
2,614,200
2,922,500
Net Income from Continuing & Discontinued Operation
-328,500
-328,500
-25,200
186,200
98,000
Normalized Income
-211,589.10
-211,589.10
-15,189
175,306
98,359
Interest Expense
123,800
123,800
69,700
200
200
Net Interest Income
-123,800
-123,800
-69,700
-200
-200
EBIT
-151,200
-151,200
39,200
187,200
136,600
EBITDA
-64,300
-64,300
137,200
280,800
302,900
Reconciled Cost of Revenue
2,160,600
2,160,600
2,243,200
2,104,500
2,453,100
Reconciled Depreciation
86,900
86,900
98,000
93,600
166,300
Net Income from Continuing Operation Net Minority Interest
-271,500
-271,500
-31,700
145,900
98,000
Total Unusual Items Excluding Goodwill
-60,700
-60,700
-20,900
-37,700
-500
Total Unusual Items
-60,700
-60,700
-20,900
-37,700
-500
Normalized EBITDA
-3,600
-3,600
158,100
318,500
303,400
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-789.10
-789.10
-4,389
-8,294
-141
12/31/2021 - 6/20/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BCYC Bicycle Therapeutics plc
8.26
-4.73%
 
MGTX MeiraGTx Holdings plc
6.53
+0.62%
 
ENTA Enanta Pharmaceuticals, Inc.
5.42
-3.20%
 
DYN Dyne Therapeutics, Inc.
11.07
+2.69%
 
GMAB Genmab A/S
20.45
+1.59%
 
MBX MBX Biosciences, Inc.
9.25
+2.89%
 
CGEM Cullinan Therapeutics, Inc.
8.10
-3.34%
 
IMVT Immunovant, Inc.
14.72
+1.87%
 
INVA Innoviva, Inc.
18.26
-0.60%
 
NUVL Nuvalent, Inc.
71.95
-1.05%